"Business Personality in Focus"

PR Agarwal
MD,Avon Organics

Hyderabad:  Mr. P R Agarwal MD of Avon Organics,completed his Engineering Course from Osmania University and his Post Graduation from Wisconsin, USA with specialisation in Design Engineering. Before starting Avon Organics he worked as a design engineer in Allwyn for a year. Mr.P.R.Agarwal is the chairman of All India Manufacturers Organisation.

Avon Organics was incorporated in August 1993 to manufacture diketene and its derivatives Monomethyl Acetoncetamide (MMA) and Methyl Acetoacetate (MAA). The company's 1200 tpa Diketene manufacturing facility located at Sadashivpet in Andhra Pradesh and the products of it were used in pigments, pharmaceuticals and pesticides.

Avon Organics has a tripartite technical know-how agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US. XTP shall be the technical supervisor for the transfer of technology, while SMEC shall supply the technical know-how.

The company has bagged the award for the Best New Product manufactured in the State of Andhra Pradesh as awarded by the Federation of Andhra Pradesh Chamber of Commerce and Industry and also certified as an ISO 9002 company by American Quality Assessors accredited with ANSI-RAB for the manufacturing and marketing MMAA, MMAE, DEA, EEAA and Aralydes.

The company had developed technology for recovery of Diketene from sludge. The company has also diversified into Bio-Technology, where the value addition is high. The Bio-Technology Plant is located at Solapur, Maharashtra for manufacture of Ephedrine and Pseudo-Ephedrine with an installed capacity of 150 MT p.a. The plant has commenced operations during April 2001. The biotech division produces Pharmaceutical intermediates i.e Pseudoephedrine and ephedrine.

The company has signed two long-term export contracts to supply fixed quantities of pseudoephedrine and is in talks with a few more MNC's for long term contracts during the year 2001-02. The company's bio-tech division is pursuing USFD approval which will enable it to enter into regulated markets.

The company currently has a turnover of Rs 100 crore.

-Maju Kuriakose
June' 2003


This site is conceived, designed, and maintained by Reach-out Business Network.
 All rights reserved world wide. Copyright  1999- 2002. Mail your queries to

Neither Reachout Business Network, nor the sources it  obtained the information from, are responsible for the correctness/validity of the information in these pages. It is a collection of both facts and opinions. You are advised to verify all information with a reliable source before acting on it. This disclaimer applies to all pages of
Reproduction in whole or in part in any form or medium without written permission of ReachoutHyderabad is prohibited.